Aptima HIV-1 RNA QT Testing Reagents

The Florida Department of Health, Bureau of Public Health Laboratories is seeking to procure Aptima HIV-1 RNA QuantDx assay testing reagents through a sole source acquisition. The department requires these reagents to perform quantitative HIV-1 RNA tests and they are compatible with the department's existing Aptima HIV-1 RNA QuantDx assay system. The total estimated value of the 3-year contract is $819,720, with $273,240 per year. The justification for the sole source procurement is that Hologic Genprobe Sales & Services is the sole manufacturer and distributor of the required HIV-1 RNA kits and reagents, and there are no other reagents that can be used on the department's existing Aptima system. Prospective vendors are requested to provide information regarding their ability to supply the required commodities or services by January 25, 2023, after which the agency will make a final determination on the single source acquisition.

The contract opportunity is limited to Hologic Genprobe Sales & Services as the sole source provider of the required HIV-1 RNA testing reagents. There are no set-aside designations or restrictions on the types of organizations that can respond. The incumbent vendor is Hologic Genprobe Sales & Services, and the department's existing Aptima HIV-1 RNA QuantDx assay system must be integrated with the new reagents. The total estimated value of the 3-year contract is $819,720.